UNSPSC 85732074: Supplement right kidney pelvis via natural or artificial opening autologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right kidney pelvis via natural or artificial opening autologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TU377Z

UNSPSC 85732074 Supplement right kidney pelvis via natural or artificial opening autologous tissue substitute, via natural or artificial opening is a Commodity code with no relevant recent state and local procurement activity. The six opportunities posted between July and September 2026 and tagged under this code—including independent medical evaluation services for retirement disability determinations (City of Phoenix), surgical procedure carve-out benefits (City of Long Beach), occupational medical surveillance (Washington State Department of Transportation), emergency and specialty care for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary health professional staffing (County of Santa Clara Health System)—are all healthcare services delivery, administration, or staffing arrangements unrelated to urological surgical procedures or tissue substitutes. The code's nominal scope and the actual work being solicited are fundamentally misaligned.

State and local procurement systems appear to have applied this code to healthcare-related RFPs and RFQs without regard to the code's specific surgical-procedure classification. No issuing body has solicited kidney pelvis reconstruction, urological tissue grafting, or related clinical procedures. Until solicitations actually addressing reconstruction of the kidney pelvis or comparable urological reconstruction work appear under this code, it signals no actionable procurement opportunity for vendors in the urological device, tissue substitute, or surgical-procedure space.